These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 24996843)
21. [National patient follow-up care logbook: Guidelines by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. de Berranger E; Balcaen S; Ainaoui M; Bompoint C; Borel C; Chevallier N; de Bentzmann N; Denis V; Kerautret K; Godin S; Labat ML; Letort-Bertrand M; Porcheron S; Magro L; Yakoub-Agha I; Guiraud M Bull Cancer; 2016 Nov; 103(11S):S273-S275. PubMed ID: 27776733 [TBL] [Abstract][Full Text] [Related]
22. [Transfer of skills: implementing post-transplant follow-up care status for transplant nurses: a report by the SFGM-TC]. Cornillon J; Peffault de Latour R; Apaza S; Bourg MA; Courbon C; Evard S; Guiraud M; Le Bars L; Petit S; Magro L; Schmitt S; Tardieu L; Samsonova O; Tipton R; Yakoub-Agha I; Pathol Biol (Paris); 2014 Aug; 62(4):190-2. PubMed ID: 24972456 [TBL] [Abstract][Full Text] [Related]
23. [How I manage respiratory syncytial virus, human herpesvirus 6 and adenovirus reactivation or infection after allogeneic stem cell transplantation: a report of the SFGM-TC]. Deconinck E; Dalle JH; Berceanu A; Chevallier P; Duléry R; Garnier A; Huynh A; Labussière-Wallet H; Nguyen Quoc S; Dewilde A; Ramon P; Yakoub-Agha I; Pathol Biol (Paris); 2013 Aug; 61(4):149-51. PubMed ID: 24011959 [TBL] [Abstract][Full Text] [Related]
24. [Vaccination post hematopoietic stem cell transplantation: which vaccines and when and, how to vaccinate? An SFGM-TC report]. Rubio MT; Charbonnier A; de Berranger E; Gandemer V; Magro L; Maury S; Sterkers G; Suarez F; Dalle JH; Daguindau E; Galumbrun C; Hermet É; Reman O; Turlure P; Yakoub-Agha I; Pathol Biol (Paris); 2013 Aug; 61(4):139-43. PubMed ID: 24011964 [TBL] [Abstract][Full Text] [Related]
25. [National care logbook for patients undergoing autologous hematopoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Porcheron S; Balcaen S; Cardinael N; Courbon C; Dendoncker C; Faivre-Lescat H; François G; Gilis L; Guiraud M; Schmitt S; Vercasson M; Adam C; Yakoub-Agha I Bull Cancer; 2017 Dec; 104(12S):S142-S144. PubMed ID: 29128082 [TBL] [Abstract][Full Text] [Related]
26. Allogeneic transplantation across major HLA barriers. Henslee-Downey PJ Best Pract Res Clin Haematol; 2001 Dec; 14(4):741-54. PubMed ID: 11924919 [TBL] [Abstract][Full Text] [Related]
27. [Polymorphism in HLA and KIR genes and the impact on hematopoietic stem cell transplantation outcomes and unrelated donor selection: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Dubois V; Brignier A; Elsermans V; Gagne K; Kennel A; Pedron B; Picard C; Ravinet A; Varlet P; Cesbron A; Delbos F; Yakoub-Agha I; Loiseau P Bull Cancer; 2016 Nov; 103(11S):S243-S247. PubMed ID: 27855950 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for late cytomegalovirus infection after allogeneic stem cell transplantation using HLA-matched sibling donor: donor lymphocyte infusion and previous history of early CMV infection. Kim DH; Kim JG; Lee NY; Sung WJ; Sohn SK; Suh JS; Lee KS; Lee KB Bone Marrow Transplant; 2004 Jul; 34(1):21-7. PubMed ID: 15133483 [TBL] [Abstract][Full Text] [Related]
29. [Improving diagnosis coding in the ProMise database: Guidelines of the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)]. Polge E; Bourgue F; Cuvelier M; Pires B; Hugon N; Laurent N; Leclerc N; Leroux S; Le Bars L; Marion S; Meziane Y; Moukhtari L; Renault M; Peffault de Latour R; Yakoub-Agha I; Raus N Bull Cancer; 2016 Nov; 103(11S):S213-S219. PubMed ID: 27842859 [TBL] [Abstract][Full Text] [Related]
30. Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Robin M; Tabrizi R; Mohty M; Furst S; Michallet M; Bay JO; Cahn JY; De Coninck E; Dhedin N; Bernard M; Rio B; Buzyn A; Huynh A; Bilger K; Bordigoni P; Contentin N; Porcher R; Socié G; Milpied N Br J Haematol; 2011 Feb; 152(3):331-9. PubMed ID: 21133885 [TBL] [Abstract][Full Text] [Related]
31. [Assessment and management of post-transplant iron overload: Guidelines of the Francophone Society of Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Jaspers A; Bouhya S; Belaiche S; Chevallier P; Hermet E; Hospital-Gustems C; Michallet M; Rialland F; Samsonova O; Sirvent A; Yakoub-Agha I; Rohrlich PS; Beguin Y Bull Cancer; 2016 Nov; 103(11S):S255-S266. PubMed ID: 27842863 [TBL] [Abstract][Full Text] [Related]
32. [Transfusion in autologous and allogenic hematopoietic stem cell transplant: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Giraud C; Thibert JB; Desbrosses Y; Debiol B; Alsuliman T; Bardiaux L; Garban F; Huynh TNP; Samsonova O; Yakoub-Agha I; Bruno B Bull Cancer; 2019 Jan; 106(1S):S52-S58. PubMed ID: 30665669 [TBL] [Abstract][Full Text] [Related]
33. Allogeneic peripheral blood hematopoietic stem cell transplantation: guidelines for red blood cell immuno-hematological assessment and transfusion practice.Société Française de Greffe de Moelle. Lapierre V; Kuentz M; Tiberghien P Bone Marrow Transplant; 2000 Mar; 25(5):507-12. PubMed ID: 10713627 [TBL] [Abstract][Full Text] [Related]
34. [Management of the chronic graft versus host disease: Guidelines from the Francophone society of bone marrow transplantation and cellular therapies (SFGM-TC)]. Magro L; Forcade E; Giraud C; Granata A; Parquet N; Rohrlich PS; Terriou L; Yakoub-Agha I; Beguin Y Bull Cancer; 2017 Dec; 104(12S):S145-S168. PubMed ID: 29174321 [TBL] [Abstract][Full Text] [Related]
35. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice. Du B; Li DP; Xu KL; Pan XY Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128 [TBL] [Abstract][Full Text] [Related]
36. [Efficacy of donor lymphocyte infusion in patients after different types of allogeneic hematopoietic stem cell transplantation]. Slesarchuk OA; Babenko EV; Semenova EV; Bondarenko SN; Éstrina MA; Morozova EV; Paina OV; Vavilov VN; Smirnov BI; Zubarovskaia LS; Afanas'ev BV Ter Arkh; 2013; 85(7):26-33. PubMed ID: 24137944 [TBL] [Abstract][Full Text] [Related]
37. [How we harmonize HSCT clinical practices among the SFGM-TC centers]. Tipton R; Yakoub-Agha I Bull Cancer; 2016 Nov; 103(11S):S193-S197. PubMed ID: 27810144 [TBL] [Abstract][Full Text] [Related]
38. Donor cell myelodysplastic syndrome after allogeneic stem cell transplantation responding to donor lymphocyte infusion: case report and literature review. Komrokji R; Ifthikharuddin JJ; Felgar RE; Abboud CN; Wedow LA; Connaughton A; Bennett JM Am J Hematol; 2004 Aug; 76(4):389-94. PubMed ID: 15282676 [TBL] [Abstract][Full Text] [Related]
39. Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factors. Yan CH; Wang JZ; Liu DH; Xu LP; Chen H; Liu KY; Huang XJ Eur J Haematol; 2013 Oct; 91(4):304-14. PubMed ID: 23837640 [TBL] [Abstract][Full Text] [Related]
40. [HLA coding in ProMISe: Guidelines from the Francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)]. Raus N; Faucher C; Kennel A; Pereira M; Veron C; Yakoub-Agha I; Loiseau P Bull Cancer; 2017 Dec; 104(12S):S65-S70. PubMed ID: 29128085 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]